Medicine for treating hyperosteogeny and its preparation method

Abstract

The invention discloses a medicine for treating hyperosteogeny and a preparation method thereof, subject to the technical field of medicine, comprises the following APIs in parts by weight: 62.5 partof radix Gentianae Macrophyllae, 62.5 part of wine clematis, 62.5 parts of notopterygium root, 62.5 copies of Kawaguchi, 62.5 part of radix Angelicae Dahuricae, 62.5 part of radix Aconiti Kusnezoffii,62.5 part of schizonepeta, Saposhnikovia divaricata 62.5 parts, 62.5 part of safflower, 62.5 part of frankincense, 62.5 part of myrrh, 62.5 part of aconite root, 62.5 part of fennel, 62.5 part of papaya, 62.5 part of radix Angelicae Pubescentis, 62.5 parts of herba Cyathulae Tuberculatae, 62.5 part of radix Cyathulae, 62.5 parts of cortex Acanthopanacis Senticosi, 62.5 parts of semen Strychni, 62.5 parts of rhizoma arisaematis, 62.5 part of caulis Spatholobi, 62.5 parts of herba Lycopodii, 62.5 parts of herba asari, 62.5 parts of white pepper, 62.5 parts of sanguis Draxonis and 62.5 parts ofradix Paeoniae alba. The invention has the characteristics of obvious curative effect, no toxic side effect and safe external application, and is suitable for popularization and application.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to a medicine for treating hyperosteogeny (thorn) and a preparation method thereof. Background technique [0002] Bone and joint degenerative changes, commonly known as hyperosteogeny, mostly occur in middle-aged and above. The etiology is related to old age, long-term strain, and exogenous wind, cold, and dampness. Due to physical weakness and degenerative diseases after middle age, long-term standing or Walking and holding a certain posture for a long time, due to muscle pulling or avulsion, bleeding, hematoma organization, forming spine-like or lip-like bone hyperplasia; bone spurs cause mechanical stimulation to soft tissues and soft tissue damage after trauma , bleeding, and swelling. [0003] For the treatment of bone hyperplasia, most clinically, oral medicines are used. Oral medicines are absorbed, digested, decomposed in the stomach, and finally passed through the blood cir...

AI Technical Summary

Problems solved by technology

[0003] For the treatment of bone hyperplasia, most clinically, oral medicines are used. Oral medicines are absorbed, digested, decomposed in the stomach, and finally passed through the blood circulation before the medicine can be delivered to the local area. The whole process needs to pass through layers of barriers to reach the lesion. However, the effect of the medicine is running out, so the effect is extremely slow and inefficient, and clinical application of these methods can only relieve pain symptoms, functional recovery is irreversible, and bone repair is impossible to talk about, and oral medicine is harmful to the liver. , kidney, and gastrointestinal damage